Somatostatin for Uveitic Cystoid Macular Edema (CME)

Purpose: To report the favorable response of bilateral recalcitrant uveitic cystoid macular edema (CME) to treatment with a somatostatin analog. Methods: Medical ophthalmic history and the results of ophthalmic examinations were recorded. Fluorescein angiography (FA) studies were reviewed. Results:...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ocular immunology and inflammation 2005-12, Vol.13 (6), p.469-470
Hauptverfasser:	Papadaki, Thekla, Zacharopoulos, Ioannis, Iaccheri, Barbara, Fiore, Tito, Foster, C. Stephen
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Hormonal - administration & dosage Antineoplastic Agents, Hormonal - therapeutic use Cystoid macular edema Female Fluorescein Angiography Follow-Up Studies Fundus Oculi Humans Injections, Subcutaneous Macular Edema - diagnosis Macular Edema - drug therapy Macular Edema - etiology Middle Aged Octreotide - administration & dosage Octreotide - therapeutic use somatostatin Somatostatin - analogs & derivatives uveitis Uveitis, Intermediate - complications
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Purpose: To report the favorable response of bilateral recalcitrant uveitic cystoid macular edema (CME) to treatment with a somatostatin analog. Methods: Medical ophthalmic history and the results of ophthalmic examinations were recorded. Fluorescein angiography (FA) studies were reviewed. Results: A 52-year-old white female with intermediate uveitis developed bilateral recalcitrant CME. Treatment with subcutaneous injections of the somatostatin analog octreotide resulted in partial resolution of the CME and improvement of visual acuity. Conclusions: Somatostatin may play a role in the treatment of CME secondary to uveitis.
ISSN:	0927-3948 1744-5078
DOI:	10.1080/09273940691001964